Bevacizumab in Treating Young Patients With Refractory Solid Tumors - Related Studies

Home

Bevacizumab in Treating Young Patients With Refractory Solid Tumors

This study has been completed.

Study NCT00085111. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Interventions listed in this trial
		bevacizumab

2	More general drug interventions related to this trial
		Angiogenesis Inhibitors
		Angiogenesis Modulating Agents
		Antineoplastic Agents
		Growth Inhibitors
		Growth Substances
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

3	Sponsors listed in this trial
		Children's Oncology Group
		National Cancer Institute (NCI)